BMC Infectious Diseases
(Accessed 29 May 2021)
Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
Favipiravir possesses high utility for treating patients with COVID-19. However, research examining the efficacy and safety of favipiravir for patients with COVID-19 is limited.
Authors: Toshie Manabe, Dan Kambayashi, Hiroyasu Akatsu and Koichiro Kudo
Citation: BMC Infectious Diseases 2021 21:489
Content type: Research article
Published on: 27 May 2021